Asia Pacific Bioanalytical Testing Services Market to Grow at 11.2% Through 2031 Reaching $13.35 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $13,359.1 million … [Read more…]

Neurosurgical Products Pipeline Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The publisher’s Medical Devices sector report, Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive … [Read more…]

Harris Williams Advises The CM Group on its Pending Sale to OPEN Health

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it is advising The CM Group, a portfolio company of NaviMed Capital (NaviMed), on its pending sale to OPEN Health, a portfolio company of Astorg. The CM Group is a leading medical communications platform offering a set of integrated solutions to … [Read more…]

North America Antibody Drug Conjugates Market Report 2022: Featuring Key Player GlaxoSmithKline, Pfizer, AstraZeneca & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Antibody Drug Conjugates Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. Market Drivers The rising prevalence of cancer is the primary driver of the antibody drug conjugates market in North America. Because cancer claims millions of lives each year and is on the rise, the … [Read more…]

Cathepsin K Inhibitor Pipeline Research Report 2022 Featuring Medivir AB, Celera Group, Merck & Co, Mateon Therapeutics, & Amura – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cathepsin K Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Cathepsin K Inhibitor – Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Cathepsin K Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism … [Read more…]

Global Isocitrate Dehydrogenase (IDH) inhibitors Pipeline Research Report 2022 Featuring Bayer, Agios Pharma, Daiichi Sankyo, & Ohm Oncology – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Isocitrate Dehydrogenase (IDH) inhibitors- Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This “Isocitrate Dehydrogenase (IDH) inhibitors – Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Isocitrate Dehydrogenase (IDH) inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage … [Read more…]

Global Corporate Wellness Market Intelligence Report 2022: Featuring Key Players Aduro, Virgin Pulse, Quest Diagnostics & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Corporate Wellness Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Corporate Wellness Market is projected to reach USD 81,715.37 million by 2027 from USD 42,138.66 million in 2021, at a CAGR 11.67% during the forecast period. Market Statistics: The Americas Corporate Wellness Market size … [Read more…]

Progesterone Receptor (PR) Antagonist Pipeline Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Progesterone Receptor (PR) Antagonist development. The report provides detailed coverage of the pipeline landscape for … [Read more…]

Global Comprehensive Metabolic Panel (CMP) Testing Markets 2021-2022 & 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel (CMP) Testing Market Analysis by Disease Type (Diabetes, Kidney Disease, Liver Disease), by End User (Point Of Contact (PoC), Laboratories), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global comprehensive metabolic panel (CMP) testing market size is estimated to be USD 12.5 billion … [Read more…]

Global Interventional Neurology Market Analysis Report 2022: Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices – Forecast to 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global interventional neurology market size is estimated to be USD 2,702.4 … [Read more…]